Regardless of Omicron, enrollment was pathetic. I disagree that Covid is "over" but unless AE gets its head out of the clouds, pivoting to cancer and NASH might be the smartest strategy.

Of course if something has changed or will change our financial position in the near future, by all means complete the Covid trial and expose the FDA's absolute failure to give LL a fair shot.